Duke Health: Vaccine Breakthrough Could Eliminate Cancer Cells For Good
The clinical trial carried out by Duke Health researchers has followed a small group of women with advanced breast cancer for over 20 years. Other news is on nasal vaccines for HPV and bird flu, an American Medical Association proposal to start its own vaccine advisory committee, and more.
Duke Health researchers recently announced groundbreaking results from a clinical trial that began over two decades ago. A small group of women with advanced breast cancer participated in a trial where they received a vaccine, and all are alive today, with robust, long-lasting immune cells that recognize their cancer. ABC11 spoke with Lori Lober, a study participant. Initially, she was given a grim prognosis, with median survival rate of less than 2 to 3% for five years. However, the trial at Duke Health gave her new hope. She has remained disease-free for 24 years. (11/16)
Read more from .
On nasal vaccines 鈥
A new study from Chiba University researchers has developed a therapeutic HPV vaccine that can be administered through the nose, offering a potential non-invasive treatment for individuals already infected with the virus. (11/17)
A new vaccine to protect dairy and poultry workers from bird flu does not require a needle and works against multiple strains of the H5N1 virus, researchers at the University of Maryland Center for Vaccine Development and Global Health said. Protection could be a quick squirt away. (Hille, 11/14)
More on vaccines and RFK Jr. 鈥
Should the American Medical Association (AMA) establish its own vaccine advisory committee or focus instead on restoring the original CDC committee? Members took up that debate during a small committee session at the AMA House of Delegates interim meeting. In June, HHS Secretary Robert F. Kennedy Jr., ousted all 17 members of the Advisory Committee on Immunization Practices (ACIP) and replaced them with people whose vaccine skepticism aligned with his own. (Firth, 11/16)
Sen. Bill Cassidy (R-La.) on Sunday said he is 鈥渧ery concerned鈥 about the possibility of changing the hepatitis B vaccine schedule for infants in the United States. Health and Human Services Secretary聽Robert F. Kennedy Jr.鈥檚聽panel of federal vaccine advisers is set to discuss and potentially vote on changing that vaccine schedule when they next meet on Dec. 4.聽On Sunday, Cassidy said he 鈥渨as concerned鈥 and that the vaccine and its ingredients, such as aluminum, which the panel is set to discuss, 鈥渉ave been shown to be safe.鈥 (Limon, 11/16)
Several Democratic candidates and organizations told POLITICO they鈥檙e betting on Robert F. Kennedy dragging down the GOP, pointing to polling showing his long-held anti-vaccine views are turning the public off. (Ollstein, 11/15)
